PineStone Asset Management Inc. Acquires 20,800 Shares of UnitedHealth Group Incorporated $UNH

PineStone Asset Management Inc. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 828,322 shares of the healthcare conglomerate’s stock after purchasing an additional 20,800 shares during the quarter. UnitedHealth Group accounts for 2.0% of PineStone Asset Management Inc.’s holdings, making the stock its 18th largest position. PineStone Asset Management Inc.’s holdings in UnitedHealth Group were worth $304,060,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in UNH. Cravens & Co Advisors LLC lifted its position in shares of UnitedHealth Group by 4.3% during the 3rd quarter. Cravens & Co Advisors LLC now owns 2,448 shares of the healthcare conglomerate’s stock valued at $899,000 after acquiring an additional 102 shares during the period. Kintegral Advisory LLC grew its holdings in shares of UnitedHealth Group by 0.6% during the 3rd quarter. Kintegral Advisory LLC now owns 7,637 shares of the healthcare conglomerate’s stock worth $2,803,000 after purchasing an additional 43 shares in the last quarter. Intergy Private Wealth LLC increased its position in shares of UnitedHealth Group by 9.1% in the third quarter. Intergy Private Wealth LLC now owns 693 shares of the healthcare conglomerate’s stock worth $254,000 after purchasing an additional 58 shares during the period. RKL Wealth Management LLC raised its stake in UnitedHealth Group by 4.8% in the third quarter. RKL Wealth Management LLC now owns 2,066 shares of the healthcare conglomerate’s stock valued at $758,000 after purchasing an additional 95 shares in the last quarter. Finally, Carroll Advisory Group LLC acquired a new position in UnitedHealth Group in the third quarter valued at about $267,000. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.19% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on UNH shares. Sanford C. Bernstein reduced their price objective on shares of UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating on the stock in a research note on Wednesday. HC Wainwright set a $500.00 target price on shares of UnitedHealth Group in a research report on Friday. Stephens set a $500.00 price target on shares of UnitedHealth Group in a report on Friday. Barclays reduced their price target on shares of UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a research report on Wednesday. Finally, DA Davidson set a $512.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $462.90.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $401.77 on Friday. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The stock’s 50-day simple moving average is $387.07 and its 200 day simple moving average is $384.64. The firm has a market capitalization of $360.62 billion, a PE ratio of 22.95, a price-to-earnings-growth ratio of 1.45 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.70 billion during the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 20.64 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were given a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s dividend payout ratio is currently 53.00%.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 results and guidance exceeded expectations. UnitedHealth reported adjusted earnings of $4.69 per share versus the $4.14 consensus estimate, while revenue of $112.7 billion also topped forecasts. Management raised its 2026 adjusted EPS outlook to at least $20.50, supporting the recovery narrative. UnitedHealth Stock Moves Higher: What’s Going On?
• Positive Sentiment: Analyst support remains significant. JPMorgan raised its price target to $524 and maintained an “overweight” rating, while Goldman Sachs reportedly lifted its target to $506 after concluding that Medicare Advantage margin recovery is progressing faster than expected. JPMorgan Raises UnitedHealth Price Target
• Positive Sentiment: Potential growth areas could support 2027 and beyond. UnitedHealth’s focus on Medicare special-needs plans, expanded coverage and care-delivery operations may provide targeted growth while improving margins. Its low beta also makes UNH attractive as a defensive healthcare holding during inflation and market rotation away from technology stocks. Can UNH’s Focus on Special Needs Plans Strengthen Medicare Growth?
• Neutral Sentiment: Recent gains may have already priced in much of the good news. Commentary noted that the earnings beat and outlook increase were followed by questions about how durable the recovery will be, limiting the immediate upside despite bullish targets. UnitedHealth Beats on Earnings, But Investors Question Growth Path
• Negative Sentiment: Membership fell and medical costs remain high. Analysts are concerned that shrinking membership and elevated utilization could constrain revenue growth and margins, particularly if higher care costs persist. This is the main reason investors are questioning whether the earnings improvement can continue. UnitedHealth’s Q3 Margins Improve, But Membership Falls
• Negative Sentiment: Analyst views are mixed. Barclays issued a pessimistic forecast, Robert W. Baird cut its price target, and TD Cowen reiterated a “hold” rating with a $402 target, signaling limited near-term upside for some investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.